Flynn RA *, Almada AE*, Zamudio JR, Sharp PA. Antisense RNA polymerase II divergent transcripts are P-TEFb dependent substrates for the RNA exosome. PNAS . July 2011 Pubmed     PDF

Flynn RA*, Almada AE*, Zamudio JR, Sharp PA.

Antisense RNA polymerase II divergent transcripts are P-TEFb dependent substrates for the RNA exosome.

PNAS. July 2011

Pubmed     PDF

Huang PH, Miraldi ER, Xu AM, Kundukulam VA, Del Rosario AM, Flynn RA , Cavenee WK, Furnari FB, White FM. Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth. Mol Bi

Huang PH, Miraldi ER, Xu AM, Kundukulam VA, Del Rosario AM, Flynn RA, Cavenee WK, Furnari FB, White FM.

Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth.

Mol Biosystems. May 2010

Pubmed     PDF

Rahl PB, Lin CY, Seila AC, Flynn RA , McCuine S, Burge CB, Sharp PA, Young RA. c-Myc regulates transcriptional pause release. Cell . April 2010 Pubmed     PDF

Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, Sharp PA, Young RA.

c-Myc regulates transcriptional pause release.

Cell. April 2010

Pubmed     PDF

Seila AC, Calabrese M, Levine SS, Yeo GW, Rahl PB, Flynn RA , Young RA, Sharp PA. Divergent transcription from active promoters. Science . December 2008 Pubmed     PDF  

Seila AC, Calabrese M, Levine SS, Yeo GW, Rahl PB, Flynn RA, Young RA, Sharp PA.

Divergent transcription from active promoters.

Science. December 2008

Pubmed     PDF

 

Huang PH, Mukasa A, Bonavia R, Flynn RA , Brewer ZE, Cavenee WK, Furnari FB, White FM. Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. PNAS . July 2007 Pubmed &nbs

Huang PH, Mukasa A, Bonavia R, Flynn RA, Brewer ZE, Cavenee WK, Furnari FB, White FM.

Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma.

PNAS. July 2007

Pubmed     PDF

Tuli R, Flynn RA , Brill KL, Sabol JL, Usuki KY, Rosenberg AL.  Diagnosis, treatment, and management of breast cancer in previously augmented women. Breast J . August 2006 Pubmed      PDF

Tuli R, Flynn RA, Brill KL, Sabol JL, Usuki KY, Rosenberg AL. 

Diagnosis, treatment, and management of breast cancer in previously augmented women.

Breast J. August 2006

Pubmed     PDF

1 2 3 4 5 6
Previous Next
Flynn RA *, Almada AE*, Zamudio JR, Sharp PA. Antisense RNA polymerase II divergent transcripts are P-TEFb dependent substrates for the RNA exosome. PNAS . July 2011 Pubmed     PDF
Huang PH, Miraldi ER, Xu AM, Kundukulam VA, Del Rosario AM, Flynn RA , Cavenee WK, Furnari FB, White FM. Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth. Mol Bi
Rahl PB, Lin CY, Seila AC, Flynn RA , McCuine S, Burge CB, Sharp PA, Young RA. c-Myc regulates transcriptional pause release. Cell . April 2010 Pubmed     PDF
Seila AC, Calabrese M, Levine SS, Yeo GW, Rahl PB, Flynn RA , Young RA, Sharp PA. Divergent transcription from active promoters. Science . December 2008 Pubmed     PDF  
Huang PH, Mukasa A, Bonavia R, Flynn RA , Brewer ZE, Cavenee WK, Furnari FB, White FM. Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. PNAS . July 2007 Pubmed &nbs
Tuli R, Flynn RA , Brill KL, Sabol JL, Usuki KY, Rosenberg AL.  Diagnosis, treatment, and management of breast cancer in previously augmented women. Breast J . August 2006 Pubmed      PDF